Literature DB >> 18082865

HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation.

Atsushi Okumura1, Tim Alce, Barbora Lubyova, Heather Ezelle, Klaus Strebel, Paula M Pitha.   

Abstract

The activation of IRF-3 during the early stages of viral infection is critical for the initiation of the antiviral response; however the activation of IRF-3 in HIV-1 infected cells has not yet been characterized. We demonstrate that the early steps of HIV-1 infection do not lead to the activation and nuclear translocation of IRF-3; instead, the relative levels of IRF-3 protein are decreased due to the ubiquitin-associated proteosome degradation. Addressing the molecular mechanism of this effect we show that the degradation is independent of HIV-1 replication and that virion-associated accessory proteins Vif and Vpr can independently degrade IRF-3. The null mutation of these two genes reduced the capacity of the HIV-1 virus to down modulate IRF-3 levels. The degradation was associated with Vif- and Vpr-mediated ubiquitination of IRF-3 and was independent of the activation of IRF-3. N-terminal lysine residues were shown to play a critical role in the Vif- and Vpr-mediated degradation of IRF-3. These data implicate Vif and Vpr in the disruption of the initial antiviral response and point to the need of HIV-1 to circumvent the antiviral response during the very early phase of replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082865      PMCID: PMC2312338          DOI: 10.1016/j.virol.2007.10.042

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  59 in total

Review 1.  Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry.

Authors:  W Popik; P M Pitha
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

Review 2.  Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein.

Authors:  Curt M Horvath
Journal:  Eur J Biochem       Date:  2004-12

Review 3.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

4.  ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.

Authors:  G Lu; J T Reinert; I Pitha-Rowe; A Okumura; M Kellum; K P Knobeloch; B Hassel; P M Pitha
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2006-05-15       Impact factor: 1.770

5.  Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3.

Authors:  W C Au; W S Yeow; P M Pitha
Journal:  Virology       Date:  2001-02-15       Impact factor: 3.616

6.  Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.

Authors:  Amy L Hartman; Jason E Dover; Jonathan S Towner; Stuart T Nichol
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation.

Authors:  R Lu; W C Au; W S Yeow; N Hageman; P M Pitha
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

8.  Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells.

Authors:  B Müller; U Tessmer; U Schubert; H G Kräusslich
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

10.  Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.

Authors:  Kate N Bishop; Rebecca K Holmes; Michael H Malim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

View more
  89 in total

1.  Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells.

Authors:  Brian P Doehle; Kristina Chang; Lamar Fleming; John McNevin; Florian Hladik; M Juliana McElrath; Michael Gale
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism.

Authors:  Brian P Doehle; Kristina Chang; Arjun Rustagi; John McNevin; M Juliana McElrath; Michael Gale
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

Review 5.  Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.

Authors:  Paola M Barral; Devanand Sarkar; Zao-zhong Su; Glen N Barber; Rob DeSalle; Vincent R Racaniello; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2009-07-15       Impact factor: 12.310

Review 6.  The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Authors:  Laurieann Casey; Xiaoyun Wen; Carlos M C de Noronha
Journal:  Cytokine       Date:  2010-03-27       Impact factor: 3.861

Review 7.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

Review 8.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 9.  Endogenous retroelements and autoimmune disease.

Authors:  Daniel B Stetson
Journal:  Curr Opin Immunol       Date:  2012-10-10       Impact factor: 7.486

10.  Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING.

Authors:  Maud Trotard; Nikolaos Tsopoulidis; Nadine Tibroni; Joschka Willemsen; Marco Binder; Alessia Ruggieri; Oliver T Fackler
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.